Philip M. Murphy
National Institutes of Health
9000 Rockville Pike
Bldg 10
Room 11N113
Name/email consistency: high
- Genetic Deletion of Chemokine Receptor Ccr6 Decreases Atherogenesis in ApoE-Deficient Mice. Wan, W., Lim, J.K., Lionakis, M.S., Rivollier, A., McDermott, D.H., Kelsall, B.L., Farber, J.M., Murphy, P.M. Circ. Res. (2011)
- Double duty for CCL21 in dendritic cell trafficking. Murphy, P.M. Immunity (2010)
- International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Murphy, P.M. Pharmacol. Rev. (2002)
- Viral exploitation and subversion of the immune system through chemokine mimicry. Murphy, P.M. Nat. Immunol. (2001)
- International union of pharmacology. XXII. Nomenclature for chemokine receptors. Murphy, P.M., Baggiolini, M., Charo, I.F., Hébert, C.A., Horuk, R., Matsushima, K., Miller, L.H., Oppenheim, J.J., Power, C.A. Pharmacol. Rev. (2000)
- Viral antichemokines: from pathogenesis to drug discovery. Murphy, P.M. J. Clin. Invest. (2000)